By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cleave Biosciences 

866 Malcolm, Suite 100

Burlingame  California  94010  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
Bay Area's Cleave Biosciences Rakes in $37 Million With Help From New Investor Celgene (CELG) 8/8/2016 6:02:22 AM
Cleave Biosciences Names Tim Smith As Chief Business Officer 6/1/2016 7:48:11 AM
Cleave Biosciences Granted Key U.S. Patent Covering CB-5083 7/30/2015 11:54:23 AM
Cleave Biosciences Receives Orphan Designation From FDA For CB-5083 For Treatment Of Multiple Myeloma 7/13/2015 6:31:27 AM
Cleave Biosciences Announces Management Changes 6/23/2015 8:02:03 AM
Cleave Biosciences To Present At JMP Securities Life Sciences Conference 2015 6/17/2015 8:57:45 AM
Cleave Biosciences To Participate In Special Session "New Drugs On The Horizon" At American Association for Cancer Research Annual Meeting 2015 4/16/2015 7:49:19 AM
Cleave Biosciences Initiates Phase 1 Clinical Trial Of CB-5083 In Patients With Advanced Solid Tumors 1/8/2015 8:16:03 AM
Cleave Biosciences Initiates Phase 1 Clinical Trial Of CB-5083 In Patients With Multiple Myeloma 9/4/2014 11:14:40 AM
Cleave Biosciences Names Alessandra Cesano As Chief Medical Officer And Lewis Shuster As Director 2/4/2014 7:14:49 AM
12
//-->